TY - CHAP M1 - Book, Section TI - Aggressive B-Cell Lymphomas A1 - Westin, Jason R. A1 - Konoplev, Sergej N. A1 - Fayad, Luis E. A1 - Medeiros, L. Jeffrey A2 - Kantarjian, Hagop M. A2 - Wolff, Robert A. Y1 - 2016 N1 - T2 - The MD Anderson Manual of Medical Oncology, 3e AB - It is clinically useful to divide non-Hodgkin lymphomas (NHL) into indolent and aggressive based on their clinical behavior (1). Patients with indolent NHL typically have a survival of many years, even if untreated, but paradoxically are usually incurable. Patients with aggressive NHL have a survival time measured in weeks to months if untreated yet are usually chemosensitive and frequently curable. In this chapter, we focus on the clinical characteristics, pathology, and treatment of aggressive NHL. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1126740581 ER -